Skip to content
Kalpvruksh Markets
Offline Log in

ONESOURCENSEOffline

ONESOURCE SPECIALTY · INE013P01021 · Small Cap · #382
1,581.90−1.70 (−0.11%)last close · 05 Nov 2026
Prev close
1,583.60
Open
—
High
—
Low
—
Volume
—
Mkt cap (6-mo avg)
₹17,838 cr
52-week range · to 05 Nov 20261,1141,877.8

Loading minute bars…

NSE 1-minute bars from our CandleApi gateway (history from 21 Jul 2026); longer timeframes are built from them. Prices not adjusted for corporate actions.

ONESOURCE is 16% below its 52-week high, above its 200-day average, ahead of Healthcare by 0.9 pts over 3 months — a Small Cap company, #382 by market cap.NSE prices to 05 Nov 2026 · a description of the data, not advice

Overview

What the data says, line by line

A description, never a buy or sell word · tap a line for its detail

  • above its 20 / 50 / 200-day averages · 16% below its 52-week high
  • ahead of its industry by 0.9 pts over 3 months · rank 5 of 44 in Healthcare · +4.1% vs Nifty 500
  • traded value 3.0× usual · delivery 56% vs 52% usual
  • FPI +0.3 pp · DII +0.8 pp · MF schemes in Sept 2026: 19 bought, 32 cut · promoter pledge 38.8% · quarter ended 2026-09-30
  • Jun 2026 quarter: profit +13539% year on year · revenue +37%
  • nothing scheduled or restricting

How big is it?

six-month average market cap

Market capitalisation
₹17,838 cr
Rank
#382
Cap band
Small Cap
Nearest cut-off — Mid / Small
−47.83% from ₹34,190 cr
Clear of the cut-off

Our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page.

Did buyers take delivery?

latest session · 2026-11-05

vs its own normal
2.3×
median 1,75,656
Delivered
4,04,058
Of volume
60%

Price & trend

Returns

to 05 Nov 2026

PeriodStockvs Nifty 500vs its industry
1 week+0.8%−4.8 pts—
1 month+3.0%−1.5 pts−0.9 pts
3 months+1.8%+4.1 pts+0.9 pts
6 months−9.3%−9.6 pts−18.2 pts
1 year−14.4%−12.2 pts—

Industry: Healthcare (Nifty 500 classification) · rank 5 of 44 over 3 months. Points = the stock’s return minus the benchmark’s. Prices adjusted for splits and bonuses.

Averages & movement

vs 20-day average
+7.0%
above
vs 50-day average
+3.8%
above
vs 200-day average
+2.0%
above
ATR (14)
4.7%
typical daily range
Volatility
56%
1 month, annualised
Beta
0.07
vs Nifty 500, 1 year
Traded value
3.0×
vs usual
Delivery
56%
usual 52%
From the 52-week high
−15.8%
place in range 61% (0 = at the low)

Ownership

Who owns the company

% of all shares, by quarter

GroupDec 25Mar 26Jun 26Sep 26
Promoters29.9%30.5% +0.630.5%30.5%
FPI19.2%17.5% −1.719.2% +1.719.4% +0.3
Mutual funds9.0%10.1% +1.113.0% +2.813.8% +0.8
Other DII9.6%10.5% +0.810.4% −0.110.4%
Individuals12.4%12.2% −0.211.3% −0.911.2% −0.1
Others19.8%19.2% −0.515.7% −3.614.7% −1.0

From the company’s quarterly shareholding pattern. Changes in percentage points against the quarter before. No quarters are on record between Sep 2022 and Jun 2025.

Promoter pledge

Sep 26

Of promoters’ holding
38.8%
Of all shares
11.8%
Jun 25 25.0%Sep 25 26.0%Dec 25 18.5%Mar 26 38.4%Jun 26 37.2%Sep 26 38.8%

Holders

Sep 26

All shareholders
79,770
Individuals
73,583

Indian passive funds’ stake

2026-06-30

Of free float
0.61%
Of all shares
0.42%
Schemes
46
Days to unwind
0.7
at 100% of volume

4,83,140 shares held by Indian passive mutual-fund schemes. A floor, not the total — foreign ETFs, insurance and EPFO are not counted.

Which funds bought and sold

mutual funds · quarter ended 2026-06-30

Funds holding
87
46 index · 41 active
Bought more
55
Sold some
11
FundSharesChangeDid
WOC Pharma and Healthcare Fund-Reg(G)Active+45,082+444.2%bought
Motilal Oswal Flexi Cap Fund-Reg(G)Active+16,90,955+272.6%bought
Motilal Oswal Special Opportunities Fund-Reg(G)Active+13,058+127.2%bought
Mirae Asset Small Cap Fund-Reg(G)Active−1,34,447−40.2%sold
LIC MF Healthcare Fund-Reg(G)Active−7,150−32.3%sold
LIC MF Value Fund-Reg(G)Active−7,235−28.9%sold

Ranked by how much each fund changed its own position, not by size of trade. Every fund here still holds the company — one that sold out entirely leaves no record to find.

Mutual-fund schemes, month by month

fund houses’ own monthly portfolios

MonthSchemesBought newAddedCutSold outShares heldValue
Sep 2680514293+1.6%₹2,216 cr
Aug 267853943−1.4%₹2,178 cr
Jul 2676643136+5.0%₹2,355 cr
Jun 267614841+1.7%₹2,281 cr
May 2676228181+6.2%₹2,483 cr
Apr 2675103692+19.3%₹2,228 cr

Each month against the one before, counting only the fund houses that reported both (45 houses in Sep 26); a split or bonus is divided out first. “Partial” = fewer than five houses reported yet.

Fund ownership is a quarterly disclosure and counts Indian passive schemes only.

Results

Results

Events & filings

Insider trades

SEBI PIT disclosures filed with NSE

Promoter group
No market buy or sell
Directors & KMP
No market buy or sell
Others
No market buy or sell
Latest 16 of 16 disclosures
0 selected
04 Feb 2026TENSHI PHARMACEUTICALS PRIVATE LIMITEDPromotersBuy85,000₹1.02 cr18.40%Market Purchase
02 Feb 2026PRONOMZ VENTURES LLPPromoter GroupBuy45,000₹5.1 cr2.41%Market Purchase
02 Feb 2026TENSHI PHARMACEUTICALS PRIVATE LIMITEDPromotersBuy2,05,000₹23.88 cr18.33%Market Purchase
30 Jan 2026PRONOMZ VENTURES LLPPromoter GroupBuy33,906₹4.05 cr2.37%Market Purchase
30 Jan 2026Tenshi Pharmaceuticals Private LimitedPromotersBuy75,000₹8.71 cr18.15%Market Purchase
28 Jan 2026Tenshi Pharmaceuticals Private LimitedPromotersBuy2,00,000₹2.08 cr18.09%Market Purchase
13 Jun 2025Pronomz Ventures LLPPromoter GroupSell51,02,548₹1,009 cr2.34%Off Market
06 Feb 2025Sajitha PillaiPromoter GroupSell5,000₹0.77 cr0.03%Market Sale
05 Feb 2025Sajitha PillaiPromoter GroupSell7,500₹1.15 cr0.03%Market Sale
03 Feb 2025Neeraj SharmaDirectorSell20,000₹2.97 cr0.12%Market Sale
03 Feb 2025Hemalatha PillaiPromoter GroupSell18,000₹2.62 cr0.00%Market Sale
31 Jan 2025Hemalatha PillaiPromoter GroupSell12,000₹1.9 cr0.02%Market Sale
31 Jan 2025Pronomz Ventures LLPPromoter GroupSell5,82,524₹90 cr6.80%Market Sale
31 Jan 2025Vineetha Mohankumar PillaiPromoter GroupSell47,500₹7.44 cr0.04%Market Sale
31 Jan 2025Padmakumar Karunakaran PillaiPromoter GroupSell50,000₹7.79 cr0.04%Market Sale

Sums count buys and sells of equity (market and off-market); pledges are listed but not summed. From NSE’s filings: the archive to 2 May 2026, its XBRL filings since (NSE circular NSE/CML/2026/12). A filing describes what was done, not why.

Disclosures & deals

last six months · NSE filings

  • Board outcome
    Onesource Specialty Pharma Limited has submitted to the Exchange, the unaudited financial results (Standalone and Consolidated) for the quarter and half year ended September 30, 2026.
    27 Oct 2026
  • Credit rating
    Onesource Specialty Pharma Limited has informed the Exchange about Credit Rating
    18 Aug 2026
  • Board outcome
    Onesource Specialty Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
    27 Jul 2026

ONESOURCE: only ratings, pledges, insider and takeover disclosures, buybacks, schemes, board outcomes and deals are listed. All deals.

Market capitalisation is our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page. Fund ownership is a quarterly disclosure and counts Indian passive schemes only. Nothing here is advice, a recommendation, or a view on the company.